{{Rsnum
|rsid=2069709
|Gene=IFNG
|Chromosome=12
|position=68159923
|Orientation=plus
|GMAF=0.007805
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=IFNG
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 91.7 | 8.3 | 0.0
| ASW | 89.5 | 8.8 | 1.8
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 92.6 | 7.4 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20939703
|Title=The Interleukin 6 -572 G&amp;gt;C (rs1800796) Polymorphism Is Associated with the Risk of Developing Acute Coronary Syndrome
}}

{{PMID Auto
|PMID=17136124
|Title=IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan.
|OA=1
}}

{{on chip | Illumina Human 1M}}